Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Bush’s Addition To 2009 Request Undermines Immediate FDA Needs – Specter

This article was originally published in The Tan Sheet

Executive Summary

Senate Appropriations Committee member Arlen Specter says President Bush's request to add $275 million to FDA's fiscal 2009 budget request undermines efforts to increase current funding

You may also be interested in...



FDA’s 2009 Funding Increase Gets First Congressional Check Mark

The House Agriculture Appropriations Subcommittee included an additional $275 million for FDA in its fiscal 2009 appropriations bill for a total of $2.1 billion in direct appropriations for the agency, which is $282 million above President Bush's budget request

FDA’s 2009 Funding Increase Gets First Congressional Check Mark

The House Agriculture Appropriations Subcommittee included an additional $275 million for FDA in its fiscal 2009 appropriations bill for a total of $2.1 billion in direct appropriations for the agency, which is $282 million above President Bush's budget request

FDA’s 2009 Funding Increase Gets First Congressional Check Mark

The House Agriculture Appropriations Subcommittee included an additional $275 million for FDA in its fiscal 2009 appropriations bill for a total of $2.1 billion in direct appropriations for the agency, which is $282 million above President Bush's budget request

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS101756

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel